Data / Form D filings / Ovala, Inc.
Ovala, Inc.: Form D filings
Ovala, Inc., a biotechnology company in Pittsburgh, PA, filed 2 Form D notices with the SEC between 2022 and 2026. The latest, on March 31, 2026, reports $3.3 million sold of a $13 million offering to 8 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2366 GOLDEN MILE HIGHWAY BOX 505, Pittsburgh, PA, 15239
- Phone
- (412) 200-7996
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1936997
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | New notice | $12,957,155 | $3,257,155 | $9,700,000 | 8 | Mar 16, 2026 | sec.gov |
| Jul 7, 2022 | New notice | $4,863,173 | $3,863,173 | $1,000,000 | 9 | Jun 22, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Stephen Bollinger | Executive Officer, Director | |
| Brad Petersen | Director | |
| Richard Petersen | Director | |
| Michael Tovian | Director | |
| Christopher Petersen | Director | |
| John Sipple | Executive Officer | |
| Jeffrey Quillen | Director |
Other biotechnology companies in Pennsylvania that filed recently
- BioLattice Ophthalmics, Inc, $1.8 million · Oct 28, 2026
- Myris Therapeutics, Inc. $500,000 · Oct 14, 2026
- Praeventix, Inc. $5.6 million · Sep 10, 2026
- Plowshare Therapies LLC $6.7 million · Aug 31, 2026
- Noveome Biotherapeutics, Inc. $6.8 million · Aug 27, 2026
- AlloTRx Bio Inc. $500,000 · Aug 24, 2026
Every Form D from the week of Mar 30, 2026 · All recent filings in Pennsylvania · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Ovala, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.